首页> 美国卫生研究院文献>Pain Research and Treatment >Treatment of Refractory Postdural Puncture Headache after Intrathecal Drug Delivery System Implantation with Epidural Blood Patch Procedures: A 20-Year Experience
【2h】

Treatment of Refractory Postdural Puncture Headache after Intrathecal Drug Delivery System Implantation with Epidural Blood Patch Procedures: A 20-Year Experience

机译:硬膜外补血治疗鞘内给药系统植入后难治性硬膜后穿刺头痛的经验:20年经验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A recent publication reported the incidence of postdural puncture headache (PDPH) in conjunction with intrathecal drug delivery system (IDDS) implantation to be nearly 23 percent. Many patients responded to conservative measures but a percentage needed invasive treatment with an epidural blood patch (EBP). There is limited data to describe the technical details, success rates, and complications associated with EBP in this population. This study aims to provide a retrospective report of EBP for patients suffering from PDPH related to IDDS implantation. A chart review established a cohort of patients that required EBP in relation to a PDPH after IDDS implantation. This cohort was evaluated for demographic data as well as details of the EBP including technical procedural data, success rates, and complications. All patients received a trial of conservative therapy. Standard sterile technique and skin preparation were utilized with no infectious complications. The EBP was placed below the level of the IDDS catheter in 94% of procedures. Fluoroscopy was utilized in each case. The mean EBP volume was 18.6 cc and median time of EBP was day 7 after implant. There were no complications associated with EBP. EBP appears to be an effective intervention in this subset of PDPH patients.
机译:最近的出版物报道硬膜外穿刺头痛(PDPH)与鞘内给药系统(IDDS)植入的发生率接近23%。许多患者对保守措施有所反应,但有一部分患者需要采用硬膜外补血(EBP)进行侵入性治疗。很少有数据可以描述该人群中与EBP相关的技术细节,成功率和并发症。这项研究旨在为与IDDS植入相关的PDPH的患者提供EBP的回顾性报告。图表回顾建立了一组在IDDS植入后需要EBP相对于PDPH的患者。评估了该队列的人口统计学数据以及EBP的详细信息,包括技术程序数据,成功率和并发症。所有患者均接受了保守治疗试验。采用标准的无菌技术和皮肤制备方法,无感染并发症。在94%的手术中,将EBP置于IDDS导管的下方。在每种情况下都使用荧光检查。平均EBP量为18.6 cc,中位时间为植入后第7天。没有与EBP相关的并发症。 EBP似乎是对PDPH患者这一子集的有效干预。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号